Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients. 

Vonita Singh, who conducts therapeutic dance classes Movement Mantra in Dubai, is herself a patient of Rheumatoid Arthritis from a very early age. She shares how she fought to overcome the physical challenges

Tell us a little about when RA started? What were the symptoms?

How does one smile and be cheerful when one wakes up with severely stiff joints and incredible pain? In the conclusion of this two-part series, Lakshmi Menon, 63, talks about the various health issues that arise as Rheumatoid Arthritis (RA) progresses and offers coping mechanisms to maintain best health.

There is a lot to learn from the life story of Jacqueline Colaco, 68, a National Hockey Champion and highly successful banker, who was struck by Rheumatoid Arthritis at age 36. But she bravely fought the disease with surgeries, medications and a positive winning-over-whining approach. Today, she is a beacon of hope and inspiration to fellow sufferers.